ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 696

Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis

Kristina SCHREIBER1, Thomas Barnetche2, BG Combe3, Jacques Morel1 and Claire I. Daien1, 1Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Lapeyronie, Montpellier, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), axial spondyloarthritis, environmental factors and tobacco use

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 8, 2015

Session Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The influence of smoking on the development of rheumatoid arthritis, the severity of the disease and the response to treatment is well established. The impact of tobacco use in patients with axial spondyloarthritis (axSpA) is only beginning to emerge. The aim of our study was to review the literature to evaluate the impact of tobacco on the development of axSpA, the activity and the severity of the disease and the therapeutic  response.

Methods: Using PUBMED database, COCHRANE and a manual search, we review the literature with the keywords: “Spondylarthropathies”[Mesh] OR “spondylitis”[Mesh] OR “spondylitis, ankylosing “[Mesh] OR “spondylarthropathy” OR spondylitis OR spondylarthropathies) AND (tobacco OR “tobacco”[Mesh] OR smoking OR “smoking”[Mesh] OR “cigarette” OR “environmental” OR “environmental factors”. The articles on psoriatic arthritis were excluded. Smoking status was divided into current smoker (CS), past smoker (PS), never smokers (NS), ever smoker (ES) with ES=CS + PS, and non-smokers= PS + NS.

Results: Among 511 articles  (493 from PUBMED, 17 from COCHRANE and one from the manual search), we include 15 articles  (2 abstracts from congress). No significant difference was found between ES and NS in terms of age at symptoms onset (-0.67 [-3.18 to 1.83]; I2 = 47%; p=0,60, n=2), on erythrocyte sedimentation rate (ESR) (+2,87 [-7.73 to13.46]; I2 = 85%; p=0.60; n=2), on C-reactive protein (CRP) (+3.12 [-2.3 to 8.55]; I2 = 89%; p=0.26; n=3), on BASDAI (+0.16 [-0.05 to 0.37]; I2 = 12%; p=0.14; n=3), and on HAQ (0.0 [-0.2- 0.2]; I2 = 83%; p=1.0; n=2). Conversely, BASFI (+0.69 [0.44 to 0.93]; I2 = 0%; p<0.001; n=3) and ASDAS-CRP was higher in ES versus NS (+0.14 [0.03to 0.25]; I2 = 0%; p=0.01; n=2).  Comparing CS to non-smokers, we found a trend to increased CRP (+2.74 [-0. 44 to 5.93]; I2 = 0%; p=0.09; n=3) and BASDAI  (+ 0.48 [-0.07to1.03]; I2 = 84%; p=0.08; n=5) and a significant increase of BASFI in (+1 [0.35 to 1,66]; I2 = 74%; p=0.003; n=5).The systematic review of literature showed that ES had higher inflammation on MRI and axial structural damage on MRI and radiographs than NS. Response to tumour necrosis factor-alpha inhibitor treatment evaluated by BASDAI 50% at 6 and 12 months was decreased in ES compared to NS.

Conclusion: Current and past smocking is associated with an increased disease activity (BASDAI and ASDAS-CRP respectively) and functional impairment. Pathogenesis remains to be determined. Smoking cessation should be encouraged in axSpA although these results suggest that it may not impact disease prognosis.


Disclosure: K. SCHREIBER, None; T. Barnetche, None; B. Combe, None; J. Morel, None; C. I. Daien, None.

To cite this abstract in AMA style:

SCHREIBER K, Barnetche T, Combe B, Morel J, Daien CI. Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/current-and-past-smoking-are-associated-with-functional-impairement-and-increased-disease-activity-in-axial-spondyloarthritis-systematic-review-and-meta-analysis/. Accessed December 14, 2019.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/current-and-past-smoking-are-associated-with-functional-impairement-and-increased-disease-activity-in-axial-spondyloarthritis-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.